This investigation reveals the impact of reaction conditions and autoxidation on catecholase activity, indicating improved reproducibility for catalytic studies.
The oxidation of 3,5-di-tert-butylcatechol (3,5-DTBC) to 3,5-di-tert-butylquinone (3,5-DTBQ) is easy to run (using O2 as an oxidant), easy to monitor by UV-vis spectroscopy (the growth of a peak at 400 nm indicates formation of the product, 3,5-DTBQ), low hazard, low cost, and biomimetic. It is therefore unsurprising that hundreds of papers report this reaction as a way to demonstrate the capacity of new complexes for oxidation catalysis. Yet between these many reports there are few commonalities in terms of the reaction conditions—with respect to solvent, reaction time, catalyst and substrate concentrations, the use of base as a co-catalyst, or buffering of the solution—and the reports even disagree on the molar absorptivity of 3,5-DTBQ, so that a direct comparison between complexes has many caveats. Indeed, our observation of significant autoxidation and base-enhanced autoxidation further motivated this study, which includes the determination of the molar absorptivity of 3,5-DTBQ in several solvents and thorough examination of the contributions of autoxidation to 3,5-DTBC oxidation by comparison with a mono-Cu catalyst both with and without added base (KOH). Initial substrate concentration, solution pH, and the time between the dissolution of 3,5-DTBC and the start of measurements can all impact the outcome of the reaction, and we report protocols with recommendations to help design catalytic trials to avoid conflating these effects with real differences in catalytic activity.
No takes yet. Share an insight, caveat, or question.
Carbajal et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: